Abstract
The serotonin3 (5-HT3) receptor plays an important role in the aminoprivic feeding model. Other neurochemical systems, including cholecystokinin (CCK) and dopamine (DA), are known to affect food intake. We pretreated rats systemically with tropisetron, a 5-HT3 receptor antagonist, alone and combined with antagonists of DA1 and DA2 receptors, and measured intake of an amino acid-imbalanced diet (IMB). As expected, tropisetron significantly increased intake of IMB. SCH-23390, a DA1 antagonist, increased IMB anorexia. When combined with tropisetron, DA2 antagonism with eticlopride reduced short-term intake of both the basal diet (BAS) and IMB. In the IMB model, specificity of 5-HT3-DA2 interactions, and of 5-HT3-CCK(A) interactions from previous studies, prompted investigation of CCK(A)-DA2 interactions; there appeared to be none. SKF-38393, a DA1 agonist, combined with the CCK(A) receptor antagonist, devazepide, increased BAS and tended to increase IMB intake. Thus, CCK(A)-DA1 interactions were not specific for IMB. These data suggest that DA1 receptor activity opposes IMB anorexia, possibly via an interaction with the 5-HT3 receptor. Copyright (C) 1999 Elsevier Science Inc.
Original language | English (US) |
---|---|
Pages (from-to) | 493-498 |
Number of pages | 6 |
Journal | Pharmacology Biochemistry and Behavior |
Volume | 62 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1999 |
Externally published | Yes |
Keywords
- Amino acid deficiency
- CCK(A) receptor
- DA receptor
- DA receptor
- Devazepide
- Eticlopride
- Food intake
- Nutrition
- SCH-23390
- SKF-38393
- Serotonin receptor
- Tropisetron
ASJC Scopus subject areas
- Biochemistry
- Toxicology
- Pharmacology
- Clinical Biochemistry
- Biological Psychiatry
- Behavioral Neuroscience